Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.
Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
While Judge Gregory Carro ruled the search of a backpack worn by Luigi Mangione—the man accused of killing UnitedHealthcare CEO Brian Thompson—was unlawful, some of its key contents will still be allowed in at trial.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
The payment program spent $484 million on 15 different low-value imaging services, a figure that balloons to $584 million when factoring for out-of-pocket costs.
California-based Heartflow, which offers an AI software that assesses coronary CT angiography scans, hopes to raise over $200 million through the stock offering.
Late-breaking data out of EuroPCR focused on 420 patients treated with Boston Scientific's new coronary IVL catheter. Overall, the device was found to be both safe and effective for patients with severe CAD.
Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.
